-
1
-
-
0034611675
-
Obesity in the new millennium
-
Friedman J.M. Obesity in the new millennium. Nature 2000, 404:632-634.
-
(2000)
Nature
, vol.404
, pp. 632-634
-
-
Friedman, J.M.1
-
2
-
-
17844388556
-
Endocannabinoid control of food intake and energy balance
-
Di Marzo V., Matias I. Endocannabinoid control of food intake and energy balance. Nat. Neurosci. 2005, 8:585-589.
-
(2005)
Nat. Neurosci.
, vol.8
, pp. 585-589
-
-
Di Marzo, V.1
Matias, I.2
-
3
-
-
48249097797
-
Endocannabinoids: synthesis and degradation
-
Di Marzo V. Endocannabinoids: synthesis and degradation. Rev. Physiol. Biochem. Pharmacol. 2008, 160:1-24.
-
(2008)
Rev. Physiol. Biochem. Pharmacol.
, vol.160
, pp. 1-24
-
-
Di Marzo, V.1
-
4
-
-
56449095685
-
Role of endocannabinoids and their analogues in obesity and eating disorders
-
Gaetani S., Kaye W.H., Cuomo V., Piomelli D. Role of endocannabinoids and their analogues in obesity and eating disorders. Eat Weight Disord. 2008, 13:e42-e48.
-
(2008)
Eat Weight Disord.
, vol.13
-
-
Gaetani, S.1
Kaye, W.H.2
Cuomo, V.3
Piomelli, D.4
-
5
-
-
42249099620
-
Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: effect of high fat diets
-
Matias I., Petrosino S., Racioppi A., Capasso R., Izzo A.A., Marzo V. Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: effect of high fat diets. Mol. Cell Endocrinol. 2008, 286:S66-S78.
-
(2008)
Mol. Cell Endocrinol.
, vol.286
-
-
Matias, I.1
Petrosino, S.2
Racioppi, A.3
Capasso, R.4
Izzo, A.A.5
Marzo, V.6
-
6
-
-
31044456243
-
The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits cell proliferation and increases markers of adipocyte maturation in cultured mouse 3T3 F442A preadipocytes
-
Gary-Bobo M., Elachouri G., Scatton B., Le Fur G., Oury-Donat F., Bensaid M. The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits cell proliferation and increases markers of adipocyte maturation in cultured mouse 3T3 F442A preadipocytes. Mol. Pharmacol. 2006, 69(2):471-478.
-
(2006)
Mol. Pharmacol.
, vol.69
, Issue.2
, pp. 471-478
-
-
Gary-Bobo, M.1
Elachouri, G.2
Scatton, B.3
Le Fur, G.4
Oury-Donat, F.5
Bensaid, M.6
-
7
-
-
13244249625
-
Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice
-
Liu Y.L., Connoley I.P., Wilson C.A., Stock M.J. Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice. Int. J. Obes. 2005, 29:183-187.
-
(2005)
Int. J. Obes.
, vol.29
, pp. 183-187
-
-
Liu, Y.L.1
Connoley, I.P.2
Wilson, C.A.3
Stock, M.J.4
-
8
-
-
33845523338
-
Effects of rimonabant (SR141716) on fasting-induced hypothalamic-pituitary-adrenal axis and neuronal activation in lean and obese Zucker rats
-
Doyon C., Denis R.G., Baraboi E.D., et al. Effects of rimonabant (SR141716) on fasting-induced hypothalamic-pituitary-adrenal axis and neuronal activation in lean and obese Zucker rats. Diabetes 2006, 55:3403-3410.
-
(2006)
Diabetes
, vol.55
, pp. 3403-3410
-
-
Doyon, C.1
Denis, R.G.2
Baraboi, E.D.3
-
9
-
-
57349088236
-
The cannabinoid CB1 receptor antagonist rimonabant stimulates 2-deoxyglucose uptake in skeletal muscle cells by regulating the expression of phosphatidylinositol-3-kinase
-
Esposito I., Proto M.C., Gazzerro P., et al. The cannabinoid CB1 receptor antagonist rimonabant stimulates 2-deoxyglucose uptake in skeletal muscle cells by regulating the expression of phosphatidylinositol-3-kinase. Mol. Pharmacol. 2008, 74(6):1678-1686.
-
(2008)
Mol. Pharmacol.
, vol.74
, Issue.6
, pp. 1678-1686
-
-
Esposito, I.1
Proto, M.C.2
Gazzerro, P.3
-
10
-
-
33847306530
-
Effects of cannabinoid receptors on skeletal muscle oxidative pathways
-
Cavuoto P., McAinch A.J., Hatzinikolas G., Cameron-Smith D., Wittert G.A. Effects of cannabinoid receptors on skeletal muscle oxidative pathways. Mol. Cell Endocrinol. 2007, 267:63-69.
-
(2007)
Mol. Cell Endocrinol.
, vol.267
, pp. 63-69
-
-
Cavuoto, P.1
McAinch, A.J.2
Hatzinikolas, G.3
Cameron-Smith, D.4
Wittert, G.A.5
-
11
-
-
36248947295
-
Blockade of cannabinoid CB1 receptors improves renal function, metabolic profile, and increased survival of obese Zucker rats
-
Janiak P., Poirier B., Bidouard J.P., et al. Blockade of cannabinoid CB1 receptors improves renal function, metabolic profile, and increased survival of obese Zucker rats. Kidney Int. 2007, 72(11):1345-1357.
-
(2007)
Kidney Int.
, vol.72
, Issue.11
, pp. 1345-1357
-
-
Janiak, P.1
Poirier, B.2
Bidouard, J.P.3
-
12
-
-
40949147440
-
The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat diet
-
Di Marzo V., Capasso R., Matias I., et al. The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat diet. Br. J. Pharmacol. 2008, 153(6):1272-1280.
-
(2008)
Br. J. Pharmacol.
, vol.153
, Issue.6
, pp. 1272-1280
-
-
Di Marzo, V.1
Capasso, R.2
Matias, I.3
-
13
-
-
53249097849
-
Cannabinoids and gastrointestinal motility: animal and human studies
-
Aviello G., Romano B., Izzo A.A. Cannabinoids and gastrointestinal motility: animal and human studies. Eur. Rev. Med. Pharmacol. Sci. 2008, 12(Suppl. 1):81-93.
-
(2008)
Eur. Rev. Med. Pharmacol. Sci.
, vol.12
, Issue.SUPPL. 1
, pp. 81-93
-
-
Aviello, G.1
Romano, B.2
Izzo, A.A.3
-
14
-
-
40149084635
-
Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet
-
Starowicz K.M., Cristino L., Matias I., et al. Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet. Obesity 2008, 16(3):553-565.
-
(2008)
Obesity
, vol.16
, Issue.3
, pp. 553-565
-
-
Starowicz, K.M.1
Cristino, L.2
Matias, I.3
-
15
-
-
79551469144
-
Expression of the cannabinoid system in muscle: effects of a high-fat diet and CB1 receptor blockade
-
Crespillo A., Suárez J., Bermúdez-Silva F.J., Rivera P., et al. Expression of the cannabinoid system in muscle: effects of a high-fat diet and CB1 receptor blockade. Biochem. J. 2001, 433(1):175-185.
-
(2001)
Biochem. J.
, vol.433
, Issue.1
, pp. 175-185
-
-
Crespillo, A.1
Suárez, J.2
Bermúdez-Silva, F.J.3
Rivera, P.4
-
16
-
-
0141828972
-
Peroxisome proliferator-activated receptors, fatty acid oxidation, steatohepatitis and hepatocarcinogenesis
-
Yu S., Rao S., Reddy J.K. Peroxisome proliferator-activated receptors, fatty acid oxidation, steatohepatitis and hepatocarcinogenesis. Curr. Mol. Med. 2003, 3:561-572.
-
(2003)
Curr. Mol. Med.
, vol.3
, pp. 561-572
-
-
Yu, S.1
Rao, S.2
Reddy, J.K.3
-
17
-
-
47349107995
-
Peroxisome proliferators-activated receptor (PPAR) modulators and metabolic disorders
-
Cho M.C., Lee K., Paik S.G., Yoon D.Y. Peroxisome proliferators-activated receptor (PPAR) modulators and metabolic disorders. PPAR Res. 2008, 2008:679137.
-
(2008)
PPAR Res.
, vol.2008
, pp. 679137
-
-
Cho, M.C.1
Lee, K.2
Paik, S.G.3
Yoon, D.Y.4
-
18
-
-
68349129115
-
Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding
-
Izzo A.A., Piscitelli F., Capasso R., et al. Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding. Br. J. Pharmacol. 2009, 158(2):451-461.
-
(2009)
Br. J. Pharmacol.
, vol.158
, Issue.2
, pp. 451-461
-
-
Izzo, A.A.1
Piscitelli, F.2
Capasso, R.3
-
19
-
-
73949083905
-
Basal and fasting/refeeding-regulated tissue levels of endogenous PPAR-alpha ligands in Zucker rats
-
Izzo A.A., Piscitelli F., Capasso R., et al. Basal and fasting/refeeding-regulated tissue levels of endogenous PPAR-alpha ligands in Zucker rats. Obesity 2010, 18(1):55-62.
-
(2010)
Obesity
, vol.18
, Issue.1
, pp. 55-62
-
-
Izzo, A.A.1
Piscitelli, F.2
Capasso, R.3
-
20
-
-
35748940300
-
Role and regulation of acylethanolamides in energy balance: focus on adipocytes and beta-cells
-
Matias I., Gonthier M.P., Petrosino S., et al. Role and regulation of acylethanolamides in energy balance: focus on adipocytes and beta-cells. Br. J. Pharmacol. 2007, 152:676-690.
-
(2007)
Br. J. Pharmacol.
, vol.152
, pp. 676-690
-
-
Matias, I.1
Gonthier, M.P.2
Petrosino, S.3
-
21
-
-
77649275461
-
Cannabinoids and the gut: new developments and emerging concepts
-
Izzo A.A., Sharkey K.A. Cannabinoids and the gut: new developments and emerging concepts. Pharmacol. Ther. 2010, 126(1):21-38.
-
(2010)
Pharmacol. Ther.
, vol.126
, Issue.1
, pp. 21-38
-
-
Izzo, A.A.1
Sharkey, K.A.2
-
22
-
-
84857300249
-
Epinephrine-dependent control of glucose metabolism in white adipose tissue: the role of α- and β-adrenergic signalling
-
Cahova M., Palenickova E., Papackova Z., Dankova H., Skop V., Kazdova L. Epinephrine-dependent control of glucose metabolism in white adipose tissue: the role of α- and β-adrenergic signalling. Exp. Biol. Med. 2012, 237(2):211-218.
-
(2012)
Exp. Biol. Med.
, vol.237
, Issue.2
, pp. 211-218
-
-
Cahova, M.1
Palenickova, E.2
Papackova, Z.3
Dankova, H.4
Skop, V.5
Kazdova, L.6
-
23
-
-
0035192389
-
Effects of cannabinoids on adrenaline release from adrenal medullary cells
-
Niederhoffer N., Hansen H.H., Fernandez-Ruiz J.J., Szabo B. Effects of cannabinoids on adrenaline release from adrenal medullary cells. Br. J. Pharmacol. 2001, 134(6):1319-1327.
-
(2001)
Br. J. Pharmacol.
, vol.134
, Issue.6
, pp. 1319-1327
-
-
Niederhoffer, N.1
Hansen, H.H.2
Fernandez-Ruiz, J.J.3
Szabo, B.4
-
24
-
-
2542499728
-
Anandamide decreases glomerular filtration rate through predominant vasodilation of efferent arterioles in rat kidneys
-
Koura Y., Ichihara A., Tada Y., Kaneshiro Y., et al. Anandamide decreases glomerular filtration rate through predominant vasodilation of efferent arterioles in rat kidneys. J. Am. Soc. Nephrol. 2004, 15(6):1488-1494.
-
(2004)
J. Am. Soc. Nephrol.
, vol.15
, Issue.6
, pp. 1488-1494
-
-
Koura, Y.1
Ichihara, A.2
Tada, Y.3
Kaneshiro, Y.4
-
25
-
-
77950624769
-
Cannabinoid CB1 receptor expression in relation to visceral adipose depots, endocannabinoid levels, microvascular damage, and the presence of the Cnr1 A3813G variant in humans
-
Bordicchia M., Battistoni I., Mancinelli L., et al. Cannabinoid CB1 receptor expression in relation to visceral adipose depots, endocannabinoid levels, microvascular damage, and the presence of the Cnr1 A3813G variant in humans. Metabolism 2010, 59(5):734-741.
-
(2010)
Metabolism
, vol.59
, Issue.5
, pp. 734-741
-
-
Bordicchia, M.1
Battistoni, I.2
Mancinelli, L.3
-
26
-
-
79960167580
-
Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice
-
Piscitelli F., Carta G., Bisogno T., et al. Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice. Nutr. Metab. 2011, 8(1):51.
-
(2011)
Nutr. Metab.
, vol.8
, Issue.1
, pp. 51
-
-
Piscitelli, F.1
Carta, G.2
Bisogno, T.3
-
27
-
-
0037059013
-
Ruderman Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation
-
Tomas E., Tsao T.S., Saha A.K., et al. Ruderman Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc. Natl. Acad. Sci. USA 2002, 99:16309-16313.
-
(2002)
Proc. Natl. Acad. Sci. USA
, vol.99
, pp. 16309-16313
-
-
Tomas, E.1
Tsao, T.S.2
Saha, A.K.3
-
29
-
-
84857784321
-
TRPV1 activation improves exercise endurance and energy metabolism through PGC-1α upregulation in mice
-
Luo Z., Ma L., Zhao Z., He H., et al. TRPV1 activation improves exercise endurance and energy metabolism through PGC-1α upregulation in mice. Cell Res. 2012, 22(3):551-564.
-
(2012)
Cell Res.
, vol.22
, Issue.3
, pp. 551-564
-
-
Luo, Z.1
Ma, L.2
Zhao, Z.3
He, H.4
-
30
-
-
34548444632
-
Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats
-
Bátkai S., Mukhopadhyay P., Harvey-White J., Kechrid R., Pacher P., Kunos G. Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats. Am. J. Physiol. Heart Circ. Physiol. 2007, 293(3):H1689-H1695.
-
(2007)
Am. J. Physiol. Heart Circ. Physiol.
, vol.293
, Issue.3
-
-
Bátkai, S.1
Mukhopadhyay, P.2
Harvey-White, J.3
Kechrid, R.4
Pacher, P.5
Kunos, G.6
-
31
-
-
78049307571
-
-
Cannabinoid receptor stimulation impairs mitochondrial biogenesis in mouse white adipose tissue, muscle, and liver: the role of eNOS, p38 MAPK, and AMPK pathways. Diabetes
-
Tedesco L., Valerio A., Dossena M., et al. Cannabinoid receptor stimulation impairs mitochondrial biogenesis in mouse white adipose tissue, muscle, and liver: the role of eNOS, p38 MAPK, and AMPK pathways. Diabetes; 59(11) (20102) 826-36.
-
(2010)
, vol.59
, Issue.11
, pp. 826-836
-
-
Tedesco, L.1
Valerio, A.2
Dossena, M.3
-
32
-
-
84859051261
-
-
Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability. Br. J. Pharmacol.
-
Alhamoruni A., Wright K.L., Larvin M., O'Sullivan S.E. Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability. Br. J. Pharmacol.; 165(8) (20122) 598-2610.
-
(2012)
, vol.165
, Issue.8
, pp. 2598-2610
-
-
Alhamoruni, A.1
Wright, K.L.2
Larvin, M.3
O'Sullivan, S.E.4
-
33
-
-
84861916493
-
At the heart of the matter: the endocannabinoid system in cardiovascular function and dysfunction
-
Montecucco F., Di Marzo V. At the heart of the matter: the endocannabinoid system in cardiovascular function and dysfunction. Trends Pharmacol. Sci. 2012, 33(6):331-340.
-
(2012)
Trends Pharmacol. Sci.
, vol.33
, Issue.6
, pp. 331-340
-
-
Montecucco, F.1
Di Marzo, V.2
-
34
-
-
80052897170
-
Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy
-
Barutta F., Piscitelli F., Pinach S., et al. Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy. Diabetes 2011, 60(9):2386-2396.
-
(2011)
Diabetes
, vol.60
, Issue.9
, pp. 2386-2396
-
-
Barutta, F.1
Piscitelli, F.2
Pinach, S.3
-
35
-
-
84879837213
-
-
Cannabinoid receptor 1 inhibition improves cardiac function and remodelling after myocardial infarction and in experimental metabolic syndrome. J. Mol. Med. (Berl),(Epub ahead of print)
-
Slavic S., Lauer D., Sommerfeld M., Kemnitz et al. Cannabinoid receptor 1 inhibition improves cardiac function and remodelling after myocardial infarction and in experimental metabolic syndrome. J. Mol. Med. (Berl). (2013) (Epub ahead of print).
-
(2013)
-
-
Slavic, S.1
Lauer, D.2
Sommerfeld, M.3
Kemnitz et, al.4
-
36
-
-
34548399410
-
TRPV1 gene knockout impairs preconditioning protection against myocardial injury in isolated perfused hearts in mice
-
Zhong B., Wang D.H. TRPV1 gene knockout impairs preconditioning protection against myocardial injury in isolated perfused hearts in mice. Am. J. Physiol. Heart Circ. Physiol. 2007, 293(3):H1791-H1798.
-
(2007)
Am. J. Physiol. Heart Circ. Physiol.
, vol.293
, Issue.3
-
-
Zhong, B.1
Wang, D.H.2
-
37
-
-
41749117999
-
Pharmacological blockade ofthe vanilloid receptor TRPV1 elicits marked hyperthermia in humans
-
Gavva N.R., Treanor J.J., Garami A., Fang L., Surapaneni S., Akrami A., et al. Pharmacological blockade ofthe vanilloid receptor TRPV1 elicits marked hyperthermia in humans. Pain 2008, 136(1-2):202-210.
-
(2008)
Pain
, vol.136
, Issue.1-2
, pp. 202-210
-
-
Gavva, N.R.1
Treanor, J.J.2
Garami, A.3
Fang, L.4
Surapaneni, S.5
Akrami, A.6
-
38
-
-
0020024760
-
Isoproterenol alters nonshivering thermogenesis in the Zucker obese rat (fafa)
-
Milam K.M., Stern J.S., Horwitz B.A. Isoproterenol alters nonshivering thermogenesis in the Zucker obese rat (fafa). Pharmacol. Biochem. Behav. 1982, 16(4):627-630.
-
(1982)
Pharmacol. Biochem. Behav.
, vol.16
, Issue.4
, pp. 627-630
-
-
Milam, K.M.1
Stern, J.S.2
Horwitz, B.A.3
-
39
-
-
0020714458
-
Brown adipose tissue in genetically obese (fa/fa) rats: response to cold and diet
-
Triandafillou J., Himms-Hagen J. Brown adipose tissue in genetically obese (fa/fa) rats: response to cold and diet. Am. J. Physiol. 1983, 244(2):E145-E150.
-
(1983)
Am. J. Physiol.
, vol.244
, Issue.2
-
-
Triandafillou, J.1
Himms-Hagen, J.2
-
40
-
-
22744444474
-
Physiological difference between obese (fa/fa) Zucker rats and lean Zucker rats concerning adiponectin
-
Oana F., Takeda H., Hayakawa K., et al. Physiological difference between obese (fa/fa) Zucker rats and lean Zucker rats concerning adiponectin. Metabolism 2005, 54(8):995-1001.
-
(2005)
Metabolism
, vol.54
, Issue.8
, pp. 995-1001
-
-
Oana, F.1
Takeda, H.2
Hayakawa, K.3
-
41
-
-
42449117932
-
Inhibitory effect of the anorexic compound oleoylethanolamide on gastric emptying in control and overweight mice
-
Aviello G., Matias I., Capasso R., Petrosino S., et al. Inhibitory effect of the anorexic compound oleoylethanolamide on gastric emptying in control and overweight mice. J. Mol. Med. 2008, 86(4):413-422.
-
(2008)
J. Mol. Med.
, vol.86
, Issue.4
, pp. 413-422
-
-
Aviello, G.1
Matias, I.2
Capasso, R.3
Petrosino, S.4
|